Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Sex-specific differences in white matter microvascular integrity after ischaemic stroke.

Etherton MR, Wu O, Cougo P, Lorenzano S, Li H, Cloonan L, Bouts MJRJ, Lauer A, Arai K, Lo EH, Feske SK, Furie KL, Rost NS.

Stroke Vasc Neurol. 2019 Sep 3;4(4):198-205. doi: 10.1136/svn-2019-000268. eCollection 2019 Dec.

2.

Redefining Normal: The Importance of White Matter Microstructural Integrity in Poststroke Outcomes.

Etherton MR, Rost NS.

Stroke. 2020 Feb;51(2):369-370. doi: 10.1161/STROKEAHA.119.027907. Epub 2020 Jan 7. No abstract available.

PMID:
31906827
3.

Normal-appearing white matter microstructural injury is associated with white matter hyperintensity burden in acute ischemic stroke.

Etherton MR, Wu O, Giese AK, Rost NS.

Int J Stroke. 2019 Dec 17:1747493019895707. doi: 10.1177/1747493019895707. [Epub ahead of print]

PMID:
31847795
4.

Rich-Club Organization: An Important Determinant of Functional Outcome After Acute Ischemic Stroke.

Schirmer MD, Ktena SI, Nardin MJ, Donahue KL, Giese AK, Etherton MR, Wu O, Rost NS.

Front Neurol. 2019 Sep 10;10:956. doi: 10.3389/fneur.2019.00956. eCollection 2019.

5.

Brain Connectivity Measures Improve Modeling of Functional Outcome After Acute Ischemic Stroke.

Ktena SI, Schirmer MD, Etherton MR, Giese AK, Tuozzo C, Mills BB, Rueckert D, Wu O, Rost NS.

Stroke. 2019 Oct;50(10):2761-2767. doi: 10.1161/STROKEAHA.119.025738. Epub 2019 Sep 12.

PMID:
31510905
6.

Big Data Approaches to Phenotyping Acute Ischemic Stroke Using Automated Lesion Segmentation of Multi-Center Magnetic Resonance Imaging Data.

Wu O, Winzeck S, Giese AK, Hancock BL, Etherton MR, Bouts MJRJ, Donahue K, Schirmer MD, Irie RE, Mocking SJT, McIntosh EC, Bezerra R, Kamnitsas K, Frid P, Wasselius J, Cole JW, Xu H, Holmegaard L, Jiménez-Conde J, Lemmens R, Lorentzen E, McArdle PF, Meschia JF, Roquer J, Rundek T, Sacco RL, Schmidt R, Sharma P, Slowik A, Stanne TM, Thijs V, Vagal A, Woo D, Bevan S, Kittner SJ, Mitchell BD, Rosand J, Worrall BB, Jern C, Lindgren AG, Maguire J, Rost NS.

Stroke. 2019 Jul;50(7):1734-1741. doi: 10.1161/STROKEAHA.119.025373. Epub 2019 Jun 10.

PMID:
31177973
7.

Spatial Signature of White Matter Hyperintensities in Stroke Patients.

Schirmer MD, Giese AK, Fotiadis P, Etherton MR, Cloonan L, Viswanathan A, Greenberg SM, Wu O, Rost NS.

Front Neurol. 2019 Mar 19;10:208. doi: 10.3389/fneur.2019.00208. eCollection 2019.

8.

White Matter Integrity and Early Outcomes After Acute Ischemic Stroke.

Etherton MR, Wu O, Giese AK, Lauer A, Boulouis G, Mills B, Cloonan L, Donahue KL, Copen W, Schaefer P, Rost NS.

Transl Stroke Res. 2019 Dec;10(6):630-638. doi: 10.1007/s12975-019-0689-4. Epub 2019 Jan 28.

PMID:
30693424
9.

Neuroimaging Paradigms to Identify Patients for Reperfusion Therapy in Stroke of Unknown Onset.

Etherton MR, Barreto AD, Schwamm LH, Wu O.

Front Neurol. 2018 May 15;9:327. doi: 10.3389/fneur.2018.00327. eCollection 2018. Review.

10.

Prestroke selective serotonin reuptake inhibitor use and functional outcomes after ischaemic stroke.

Etherton MR, Siddiqui KA, Schwamm LH.

Stroke Vasc Neurol. 2018 Jan 13;3(1):9-16. doi: 10.1136/svn-2017-000119. eCollection 2018 Mar.

11.

Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study.

Harris WS, Tintle NL, Etherton MR, Vasan RS.

J Clin Lipidol. 2018 May - Jun;12(3):718-727.e6. doi: 10.1016/j.jacl.2018.02.010. Epub 2018 Mar 2.

12.

Telestroke for the Newly Minted Vascular Neurologist.

Etherton MR, Schwamm LH.

Stroke. 2018 Apr;49(4):e162-e164. doi: 10.1161/STROKEAHA.117.020548. Epub 2018 Mar 6. Review. No abstract available.

PMID:
29511127
13.

Structural Integrity of Normal Appearing White Matter and Sex-Specific Outcomes After Acute Ischemic Stroke.

Etherton MR, Wu O, Cougo P, Giese AK, Cloonan L, Fitzpatrick KM, Kanakis AS, Boulouis G, Karadeli HH, Lauer A, Rosand J, Furie KL, Rost NS.

Stroke. 2017 Dec;48(12):3387-3389. doi: 10.1161/STROKEAHA.117.019258. Epub 2017 Nov 10.

14.

Diffuse microvascular dysfunction and loss of white matter integrity predict poor outcomes in patients with acute ischemic stroke.

Rost NS, Cougo P, Lorenzano S, Li H, Cloonan L, Bouts MJ, Lauer A, Etherton MR, Karadeli HH, Musolino PL, Copen WA, Arai K, Lo EH, Feske SK, Furie KL, Wu O.

J Cereb Blood Flow Metab. 2018 Jan;38(1):75-86. doi: 10.1177/0271678X17706449. Epub 2017 May 8.

15.

Integrity of normal-appearing white matter and functional outcomes after acute ischemic stroke.

Etherton MR, Wu O, Cougo P, Giese AK, Cloonan L, Fitzpatrick KM, Kanakis AS, Boulouis G, Karadeli HH, Lauer A, Rosand J, Furie KL, Rost NS.

Neurology. 2017 May 2;88(18):1701-1708. doi: 10.1212/WNL.0000000000003890. Epub 2017 Apr 5.

16.

Infarct topography and functional outcomes.

Etherton MR, Rost NS, Wu O.

J Cereb Blood Flow Metab. 2018 Sep;38(9):1517-1532. doi: 10.1177/0271678X17700666. Epub 2017 Mar 27. Review.

17.
18.

"All the soarings of my mind begin in my blood:" central nervous system complication of Waldenström macroglobulinemia.

Levin SN, de Gusmao CM, Etherton MR, Will Rondeau M, Meredith DM, Folkerth RD, Klein JP, Nadeem O, Castillo JJ.

Am J Hematol. 2016 Oct;91(10):1057-60. doi: 10.1002/ajh.24476. Epub 2016 Jul 29. No abstract available.

19.

Clinical Reasoning: A 68-year-old man with a history of lung cancer presenting with right-sided weakness and aphasia.

Gupta A, Etherton MR, McKee K, Baker JM, Izzy S, Feske SK.

Neurology. 2015 Oct 6;85(14):e104-7. doi: 10.1212/WNL.0000000000001992. No abstract available.

20.

A Man in His 40s With Headache, Lethargy, and Altered Mental Status.

McKee KE, Etherton MR, Lovitch SB, Gupta AS, Micalizzi DS, Tierney T, Wadleigh M, Vaitkevicus H.

JAMA Neurol. 2015 Sep;72(9):1061-5. doi: 10.1001/jamaneurol.2015.1375.

21.

HIV-associated Neurocognitive Disorders and Antiretroviral Therapy: Current Concepts and Controversies.

Etherton MR, Lyons JL, Ard KL.

Curr Infect Dis Rep. 2015 Jun;17(6):485. doi: 10.1007/s11908-015-0485-6.

PMID:
25916996
22.

A 20-year-old man with back pain and lower extremity weakness.

Etherton MR, Neagu MR, Oakley DH, Koch MJ, Shin JH, Frosch MP, Berkowitz AL, Dietrich J.

JAMA Neurol. 2015 Mar;72(3):363-6. doi: 10.1001/jamaneurol.2014.3833.

PMID:
25621865
23.

Fungal infections of the central nervous system.

Jacobs CS, Etherton MR, Lyons JL.

Curr Infect Dis Rep. 2014 Dec;16(12):449. doi: 10.1007/s11908-014-0449-2.

PMID:
25348744
24.

An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus.

Etherton MR, Tabuchi K, Sharma M, Ko J, Südhof TC.

EMBO J. 2011 Jun 3;30(14):2908-19. doi: 10.1038/emboj.2011.182.

25.

Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Burré J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Südhof TC.

Science. 2010 Sep 24;329(5999):1663-7. doi: 10.1126/science.1195227. Epub 2010 Aug 26.

26.

Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior.

Blundell J, Blaiss CA, Etherton MR, Espinosa F, Tabuchi K, Walz C, Bolliger MF, Südhof TC, Powell CM.

J Neurosci. 2010 Feb 10;30(6):2115-29. doi: 10.1523/JNEUROSCI.4517-09.2010.

27.

Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments.

Etherton MR, Blaiss CA, Powell CM, Südhof TC.

Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17998-8003. doi: 10.1073/pnas.0910297106. Epub 2009 Oct 12.

28.

A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice.

Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM, Südhof TC.

Science. 2007 Oct 5;318(5847):71-6. Epub 2007 Sep 6.

29.

Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2.

Chubykin AA, Atasoy D, Etherton MR, Brose N, Kavalali ET, Gibson JR, Südhof TC.

Neuron. 2007 Jun 21;54(6):919-31.

30.

Partitioning and assembly of metal particles and their bioconjugates in aqueous two-phase systems.

Helfrich MR, El-Kouedi M, Etherton MR, Keating CD.

Langmuir. 2005 Aug 30;21(18):8478-86.

PMID:
16114960
31.

Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors.

Lu Q, Yang YT, Chen CS, Davis M, Byrd JC, Etherton MR, Umar A, Chen CS.

J Med Chem. 2004 Jan 15;47(2):467-74.

PMID:
14711316
32.

Identification of antimicrobial targets using a comprehensive genomic approach.

Yin D, Fox B, Lonetto ML, Etherton MR, Payne DJ, Holmes DJ, Rosenberg M, Ji Y.

Pharmacogenomics. 2004 Jan;5(1):101-13.

PMID:
14683422

Supplemental Content

Loading ...
Support Center